SG/CALL/SARTORIUS STEDIM BIO/295/0.025/21.06.24 Share Price

Warrant

881PS

DE000SW1TXB9

Real-time Euronext Paris 17:30:00 13/05/2024 BST
0.014 EUR +27.27% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/295/0.025/21.06.24
Current month-3.45%
1 month-93.33%
Date Price Change Volume
13/05/24 0.014 +27.27% 10
10/05/24 0.011 0.00% 9
09/05/24 0.011 -24.14% 12
08/05/24 0.0145 0.00% 8
07/05/24 0.0145 +7.41% 26

Real-time Euronext Paris

Last update May 13, 2024 at 05:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
881PS
ISINDE000SW1TXB9
Date issued 03/08/2023
Strike 295
Maturity 21/06/2024 (39 Days)
Parity 40 : 1
Emission price 0.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.975
Lowest since issue 0.0105
Spread 0.012
Spread %60.00%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. 881PS Warrant